KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Non-Current Assets (2017 - 2025)

Novartis Ag (NVS) has disclosed Non-Current Assets for 9 consecutive years, with $80.5 billion as the latest value for Q4 2025.

  • Quarterly Non-Current Assets rose 10.96% to $80.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.5 billion through Dec 2025, up 10.96% year-over-year, with the annual reading at $80.5 billion for FY2025, 10.96% up from the prior year.
  • Non-Current Assets hit $80.5 billion in Q4 2025 for Novartis Ag, up from $72.5 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $86.1 billion in Q4 2021 to a low of $69.5 billion in Q4 2023.
  • Historically, Non-Current Assets has averaged $77.8 billion across 5 years, with a median of $80.5 billion in 2025.
  • Biggest five-year swings in Non-Current Assets: fell 13.76% in 2023 and later increased 10.96% in 2025.
  • Year by year, Non-Current Assets stood at $86.1 billion in 2021, then dropped by 6.43% to $80.5 billion in 2022, then dropped by 13.76% to $69.5 billion in 2023, then increased by 4.43% to $72.5 billion in 2024, then rose by 10.96% to $80.5 billion in 2025.
  • Business Quant data shows Non-Current Assets for NVS at $80.5 billion in Q4 2025, $72.5 billion in Q4 2024, and $69.5 billion in Q4 2023.